Trial intelligence / Profile preview

Early menopause HRT effects on cardiovascular health, cognition, and quality of life

ChiCTR-TRC-06000011Phase 4Completed

Sponsor
West China Second University Hospital
Start
Dec 2004
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of conjugated estrogens and medroxyprogesterone acetate in menopause (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Quality of life and Assessment for health status. Started Dec 2004; status: completed.

02

Drugs

conjugated estrogensmedroxyprogesterone acetate
03

Conditions

menopause

Beyond the preview

Go deeper on ChiCTR-TRC-06000011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-06000011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call